Cambridge Investment Research Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $435K | Buy |
16,986
+419
| +3% | +$10.7K | ﹤0.01% | 2669 |
|
|
2025
Q1 | $455K | Buy |
16,567
+2,663
| +19% | +$73.1K | ﹤0.01% | 2535 |
|
|
2024
Q4 | $375K | Buy |
+13,904
| New | +$375K | ﹤0.01% | 2658 |
|
|
2023
Q3 | – | Sell |
-15,572
| Closed | -$408K | – | 3185 |
|
|
2023
Q2 | $408K | Sell |
15,572
-8,151
| -34% | -$214K | ﹤0.01% | 2283 |
|
|
2023
Q1 | $619K | Buy |
23,723
+5,808
| +32% | +$152K | ﹤0.01% | 1942 |
|
|
2022
Q4 | $491K | Buy |
+17,915
| New | +$491K | ﹤0.01% | 2027 |
|